Publication Name	World Journal of Gastroenterology
Manuscript ID	3336
Country	China

Received	2013-04-23 13:48
Peer-Review Started	2013-04-23 21:17
To Make the First Decision
Return for Revision
Revised	2013-04-26 13:59
Second Decision	2013-05-09 14:15
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief	2013-05-10 07:10
Articles in Press
Publication Fee Transferred
Edit the Manuscript by Language Editor	2013-05-16 21:58
Typeset the Manuscript	2013-06-02 10:39
Publish the Manuscript Online	2013-06-14 23:10

ISSN	1007-9327 (print) and 2219-2840 (online)
Open Access
Copyright
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Gastroenterology & Hepatology
Manuscript Type	Field of Vision
Article Title	Controversy over the use of intraoperative blood salvage autotransfusion during liver transplantation for hepatocellular carcinoma patients
Manuscript Source	Invited Manuscript
All Author List	Bo Zhai and Xue-Ying Sun
Funding Agency and Grant Number
Corresponding Author	Xue-Ying Sun, MD, PhD, Professor, Hepatosplenic Surgery Center, Department of General Surgery, the First Affiliated Hospital of Harbin Medical University, Harbin 150001, Heilongjiang Province, China. kevsun88@hotmail.com
Key Words	Intraoperative blood salvage autotransfusion; Liver transplantation; Hepatocellular carcinoma; Leukocyte depletion filters; Allogeneic blood transfusion
Core Tip	The use of intraoperative blood salvage autotransfusion (IBSA) in hepatocellular carcinoma (HCC) patients undergoing liver transplantation is controversial as it may reinfuse salvaged blood contaminated by tumor cells. In this article, we reviewed the relevant literature and tried to address the critical questions about IBSA. The available data indicate that IBSA is safe in liver transplantation for HCC, but randomized, controlled and prospective trials are urgently required to clarify the uncertainty.
Publish Date	2013-06-14 23:10
Citation	Zhai B, Sun XY. Controversy over the use of intraoperative blood salvage autotransfusion during liver transplantation for hepatocellular carcinoma patients. World J Gastroenterol 2013; 19(22): 3371-3374
URL	http://www.wjgnet.com/1007-9327/full/v19/i22/3371.htm
DOI	http://dx.doi.org/10.3748/wjg.v19.i22.3371

Full Article (PDF)	WJG-19-3371.pdf
Manuscript File	3336-Review.doc
Answering Reviewers	3336-Answering reviewers.doc
Copyright License Agreement	3336-Copyright assignment.PDF
Peer-review Report	3336-Peer review(s).pdf
Scientific Editor Work List	3336-Scientific editor work list.doc